SC asks ex-Ranbaxy promoters to apprise how they’ll comply with Rs 3500 cr arbitral award
The bench headed by Chief Justice Ranjan Gogoi has asked the Singh brothers who promoted the pharmaceutical company, to appear…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Lupin responds to US FDA’s OAI letter
Lupin is in the process of sending further updates of its corrective actions to the US FDA and remains hopeful of a positive…
At times, a revolution is the best response to competition
Any profitable model of business is bound to attract competition. The lessons you pick up from dealing with this new enemy often…
Pall Corporation in agreement with ARTeSYN Biosolutions
Under the agreement, Pall Biotech will distribute ARTeSYN’s standard hardware and liner components off the shelf
Kiran Mazumdar-Shaw conferred with honorary doctorate from Deakin University, Australia
She was recognised for her pioneering entrepreneurial role in the field of biotechnology and for her sustained significant…
Roche’s Tecentriq notches win in breast cancer with US approval
The FDA’s OK was based on a trial that showed the drug cocktail helped stave off the disease’s advance by a median 7.4 months,…
Bayer Roundup cancer trial goes to jury after closing arguments
Hardeman’s lawyer, during her closing arguments had said Hardeman had “extreme” exposure to Roundup, spraying the chemical more…
National Cancer Institute chief Norman Sharpless to serve as acting FDA head
Cancer experts and advocates praised the appointment of Sharpless as acting FDA chief after Scott Gottlieb’s abrupt resignation…
Regeneron/Sanofi wins US approval for expanded use of skin drug
The US Food and Drug Administration said it approved expanded use of Regeneron Pharmaceuticals Inc and Sanofi SA’s eczema drug…
SPARC inks research collaboration pact with China’s HitGen
Under the terms of the agreement, HitGen will receive upfront payment and will be eligible for certain milestone payments